非癌症末期病人 / 家屬之需求 與照顧 - 以末期腎臟病患為例 - 馬偕醫院 腎臟內科 葉瑞圻醫師
ESRD 治療模式 血液透析 (H.D.) 腹膜透析 (CAPD) 腎臟移植 支持療法 * 飲食療法 * 症狀控制 * 控制血壓及代謝問題 * 防治併發症 * 緩和照護
慢性腎病分期 肌酸酐清除率 防治目標 : 毫升 / 分 1 >90 1. 篩檢 : 確立診斷 2. 找出危險因子 2 3 60-89 30-59 1. 防治疾病 ( 全人 ) 2. 減低危險因子 3. 延緩惡化 4. 防治併發症 4 15-29 準備替代療法 5 <15 透析 / 移植
Palliative Care Model of ESRD curative 1. Screening and investigation of CKD 2.Management of reversible factor bereavement Dialysis and Transplant Life-prolonging Quality of life Terminal care Supportive therapies**: palliative, rehabilitation, spiritual *Anemia management, access, nutrition, BP control, advance care planning, etc. Modified from Sheffield model of chronic disease, and Jean L. Holley Seminars in Dialysis vol. 18, No. 2, 2005
末期腎臟病 ESRD=CKD5 1.PREDIALYSIS PATIENT 2.DIALYSIS PATIENT 3.TERMINAL DIALYSIS PATIENT
台灣三高增加心腦腎病 腦中風 CKD 冠心症 糖尿病 2.9 2.4 1.5 高血壓 2.8 1.7 1.9 高血脂 2.4 1.6 1.8
滿足需求 提昇療護與 生活品質保健 PREDIALYSIS 保健延緩透析來臨 1. 衛教 2. 協助自我 DIALYSIS TERMINAL 好的透析品質 善終 1. 解釋檢驗報告 2. 建議改善方針 1. 停止透析 2. 提供安寧臨終照護
台灣透析病人現況 1. 盛行率與新增病人全球第一 2. 約 6 萬人透析.92%HD.8%CAPD 3. 每年增加約 5000 人 4. 健保費用一年 338 億 5. 開始透析年齡 :60 歲 6.50% 活 8 年半 7. 家庭支持照顧良好 8. 新增病人以糖尿病最多
透析病人 / 家屬需求 1. 優良的透析品質減輕症狀. 痛苦 2. 醫護人員多關懷醫師的關懷. 鼓勵. 提昇病人 / 家屬的自我照顧及生活品質 3. 瞭解定期的檢驗報告 4. 協助病人透過飲食. 藥物. 運動諮詢, 盡力達成好的透析品質
Indications of Dialysis in ESRD Pericarditis Fluid overload or pulmonary edema Progressive uremic encephalopathy Bleeding diathesis attributable to uremia Persistent nausea vomiting and Anorexia Plasma creatinine concentration >10-12 mg/dl or BUN >100 mg/dl Persistent pruritus or restless leg syndrome
Lift threatening complications of ARF 1.acute pulmonary edema 2.Hyperkalemia 3.Metabolic acidosis
慢性腎衰竭及腎衰竭, 未明示者 ( 一 ) 本項適用主診斷 585 ( 慢性腎衰竭 ;chronic renal failure ) 及 586 ( 腎衰竭, 未明示者 ; renal failure, unspecified) 兩項疾病末期定義 : 1. 慢性腎臟病至末期腎臟病階段, 尚未接受腎臟替代療法病患, 屬慢性腎臟病 ( CKD) 第 4,5 期病患 (GFR <30 ml/min/1.73m2), 或已接受腎臟替代療法 ( 血液透析 腹膜透析 腎臟移植 ) 病患 2. 病人因嚴重之尿毒症狀, 經原腎臟照護團隊評估病患可能在近期內死亡
慢性腎衰竭及腎衰竭, 未明示者 ( 二 ) 3. 病人在自由意識的選擇與自主的決定不願意, 或因合併下列疾病狀況之一, 不適合新繼續接受長期透析冶療或接受腎臟移植者 : 其他重要器官衰竭及危及生命之合併症 長期使用呼吸器 嚴重感染性疾病合併各項危及生命之合併症 惡病質 或嚴重之營養不良危及生命者 惡性瘇瘤末期患者 因老衰 其他系統性疾病, 生活極度仰賴他人全時照顧, 並危及生命者
急性腎衰竭, 未明示者 ( 一 ) (acute renal failure, unspecified) 1. 已接受腎臟替代療法 ( 血液透析 腹膜透析 腎臟移植 ) 病患 2. 病人因嚴重之尿毒症狀, 經原腎臟照護團隊評估病患可能在近期內死亡
急性腎衰竭, 未明示者 ( 二 ) (acute renal failure, unspecified) 3. 病人在自由意識的選擇與自主的決定不願意, 或因合併下列疾病狀況之一, 不適合繼續接受長期透析冶療或接受腎臟移植者 : 其他重要器官衰竭及危及生命之合併症 長期使用呼吸器 嚴重感染性疾病合併各項危及生命之合併症 惡病質 或嚴重之營養不良危及生命者 惡性瘇瘤末期患者 因老衰 其他系統性疾病, 生活極度仰賴他人全時照顧, 並危及生命者
Component of P.C in ESRD 1. Pain and symptom management 2. Advance care planning 3. Psychosocial and spiritual support 4. Ethical issue in dialysis Shared decision-making in the appropriate initiation of and withdrawal from dialysis Seminars in Dialysis, Vol. 18, No. 2, 2005
Definition of ACP (advance care planning) ACP is a process of communication among patients, families, health care providers, and other important individuals about the patient s preferred decision-maker and appropriate future medical care if and when a patient is unable to make his or her owe decisions
Components of ACP ( 一 ) 1. The document: instruction directives are developed in accord with the person s wishes, values, life goals 2. The participants: patient-family. Physicians and or dialysis unit staff to initiate discussions of ACP and advance directives
Components of ACP ( 二 ) 3. The purpose: Completion of a written advance directive Prepare for death Strengthen relationships Relieve burdens on loved ones
Usefulness of ACP in the ESRD population Decision making easier if ACP has occurred and advance directives exist Who have advance directives experience better, more reconciled deaths Avoid futile end-of-life therapeutic interventions
預備與抉擇 預立遺囑 預立醫療委任代理人書 預立選擇安寧緩和醫療意願書 選擇安寧緩和醫療意願書 預立不施行心肺復甦術意願書 不施行心肺復甦術意願書
6 markers of good practice of stopping dialysis 1. Access to communication skills and knowledge of symptom control 2. Offering prognostic assessment 3. Timely information and joint palliative care plan 4. Ongoing medical care for patients option not to dialyse 5. Dying with dignity 6. Culturally appropriate bereavement support http://www.kidney.org.uk/medical-info/other/discontinuing-treatment.html
Preparing to stop Dialysis Early discussion Dialysis seminars Treatment plan
Early discussion Benefits, harms and limits of dialysis. Time- limited benefit. Religious and culture factors.
Dialysis seminars Provide information on tech and scientific aspect of dialysis. Aid patient and families dealing with physical, emotional and spiritual problems related to illness. Develop mutual trust become friends.
Treatment plan Use dialysis Medical indications for stopping dialysis. DNR Emphasize stopping dialysis may avoid futile suffering and lead to dignified and good death. * death usually rapid ( mean 8.2 days ) * relatively little suffering
ESRD End-of-Life Symptom Management ( 一 ) 1. Pain: WHO guidelines (1) Fentanyl: drug of choice (2) Morphine: reduce dosage (3) Meperidine contraindicated 2. Myoclonic jerks: benzodiazepines, eg, lorazepam
ESRD End-of-Life Symptom Management ( 二 ) 3. Hunger and thirst: full diet if desired 4. Dyspnea: Opioids and ultrafiltration if necessary to avoid pulmonary edema 5. Excessive secretions : Scopolamine JAMA 2003; 289:2113-19
基本資料 : 美加八家透析中心 131 病患 (Dialysis Discontinuation and palliative care) AJKD Jul 2000 女 : 男 =6:4 白人 73% 黑人 22% 其他 6% 年齡 : 平均 70 歲 (17-89 歲 ) 透析歲月 : 平均 34 月 (3-167 月 ) CRF 原因 :1. DM(46%) 2. HT(29%) 3. GN(10%) 透析方式 :1. HD(83%) 2. CAPD(11%) 3.CCPD(5%) 4. Home HD(2%)
Comorbidity 77% dialysis patients had 3-7 comorbidities 1. Neurological : 64% 2. C.V. : 63% Specific comorbidity 1.CAD : 50% 2. PVD : 50% 3. poorly controlled HT : 38%
Reason of withdraw from dialysis Autonomy and belief of patients families. Promise of a good death by physician.
Consciousness level 48 hours after withdrawal from dialysis alert : 43% somnolent : 46% coma : 11%
Symptoms during the last 24 hours among 79 patients follows up Symptom Present Severe ( % ) ( % ) Pain 42 5 Agitation 30 1 Myoclonus or muscle twitching 28 4 Dyspnea or agonal breathing 25 3 Fever 20 - Diarrhea 14 1 Dysphagia 14 - Nausea 13 1
Treatment Medication 1. pain medication : 87% at least one occasion 2. analgesic : 9% 3. no pain medication : 4% O2 therapy : 22% Ultrafiltration for pulmonary distress : None
Place of terminal care Hospital : 61% Nursing home : 24% Inpatient hospice : 2% At home : 13%
Good death Effectiveness : 93% (from caregiver and/or families) Die alone : 29% Families and/or staff present 71% mean survival time 8.2 days. 1. 50% within 6 days 2. 5 patients in 30-46 days 3. 10 patients <2 days
Incorporating Palliative Care into Dialysis Unit Educational in-services on palliative care topics Advance care planning Pain & symptom assessment and treatment protocols Communication of prognosis and changes in condition Referral to hospice when terminally ill QI with review of quality of death
Shared Decision-Making in the Appropriate Initiation of and withdrawal from dialysis Shared Decision- Making Informed Consent or Refusal Estimating Prognosis Conflict Resolution Advance Directive Withholding or Withdrawing Dialysis Special Patient Groups Time-Limited Trials Palliative Care RPA/ASN. 2000.
案例 1 張女士 69 歲 DM, Triopathy, ESRD, CHF FC III, CAD & TVD S/P CABG, PAOD, gangrene of toes. Cr:3.9, 即使使用最大劑量之利尿劑, 每日排尿量少於 50ml, 常因肺水腫反覆入院, 血液透析後, 心衰竭現象有改善 ( 建議長期血液透析, 使體內水份保持平衡 )
案例 2 陸先生 47 歲末期腎病長期接受血液透析, 因嚴重背痛, 胸腰椎 X 光顯示 T6,T9,T11,L2 壓迫性骨折及骨鬆症, 於 95 年 1 月 18 日入院接受核磁共振檢查及治療, 住院第八日 ( 即 95 年 1 月 25 日 ) 上洗手間時突發意識昏迷, 四肢無力, 瞳孔對光反應微弱, 經插管急救, 轉入 ICU,CT 顯示中腦和小腦大量出血, 漫延到大腦室, 緊急會診神經外科
案例 2 外科醫師告訴家屬病情不適開刀, 預後不好 當時意識昏迷, 靠昇壓藥維持血壓, 與呼吸器維生 與家屬充分溝通後, 延後一天血液透析, 隨後病情惡化, 家屬同意 DNR, 終止血液透析後第四天即往生
案例 3 李先生,73 歲, hepatoma, liver cirrhosis, ascites, splenomegaly,thrombocytopenia. 因牙齦不停地流血及腹瀉而入院 住院時 Cr:3.0(CKD stage IV), Ht : 224%, platelet : 25000/mm3. 經過輸血小板及冷凍血漿等支持療法 第四天,creatinine 漸漸上升到 7.9mg%, CCr= 7ml/min ; 同時發燒 40C, CXR acute pulmonary edema, r/o sepsis, 有呼吸衰竭現象
案例 3 給予插管及呼吸器的補助冶療 同時又合併急性腎衰竭, 第六天,creatinine :12mg%, 與家屬溝通後, 先後以血液透析冶療共六次 最後, 因併發 pneumonia, hepatic encephalopathy, deep coma ; 與家屬溝通後, 停止 HD 四天後往生
案例 4 陳女士 82 歲 polio, bilateral femoral neck fracture, CKD-stage V, CHF (Fc III- IV), bilateral pleural effusion, myelodysplastic syndrome. 98 年 4 月 2 日因 shortness of breath, shock ( r/o pneumonia ) 入院
案例 4 經冶療六天病情改善而出院 98 年 4 月 11 日因 OHCA, 經 CPR, 插管及接呼吸器緊急冶療後而入院 當時 creatinine :6.3mg% ; deep coma. 與家屬溝通後, 決定 palliative care, 而沒有 HD. 五天後往生
Recommend To Palliative Care There is an option for ESRD patients who choose to stop or not to start dialysis: continued palliative care. 轉介安寧或共同照護 提供居家療護 對家屬的哀傷支持
Palliative Care Model of ESRD curative 1. Screening and investigation of CKD 2.Management of reversible factor bereavement Dialysis and Transplant Life-prolonging Quality of life Terminal care Supportive therapies**: palliative, rehabilitation, spiritual *Anemia management, access, nutrition, BP control, advance care planning, etc. Modified from Sheffield model of chronic disease, and Jean L. Holley Seminars in Dialysis vol. 18, No. 2, 2005
結論 ( 一 )TQM and CQI of ESRD 1 DM,HT,CVD,PAOD,Gout,Hyperlipidemia 篩檢高危險群 2 FHx of renal disease 3 pre-ht,pre-dm,ms,obesity 4 長期服用不明藥物或保健食品, 抽菸, 嚼檳榔早期診斷並治療可恢復的腎病 確立 CKD 分期, 執行各期照護 找出並矯正腎功能惡化因素, 並預防併發症 準備替代療法
結論 ( 二 )ESRD 照護的理念與目標 1 充實團隊能力, 與病人分享保健保腎知識, 鼓勵 協助病人自我照顧 2 目標: 整全的照護, 不斷地品質改善, 落實安寧照護理念 : 四全 / 五全全人照護全程照護全家照護全隊照護全民教育
ESRD 安寧照護之結論 對末期腎臟病患, 醫師宜充分向病患及家屬解釋治療方式及估計預後, 一切以病患的利益和自主權著想, 尊重病患選擇的治療方式 適當機會或腎友聚會時, 討論可能面臨的終止透析和 CPR 的議題 團隊具備專業技能, 尤其安寧緩和照護 理念與能力, 才能照顧病患, 維持好的生命品質 ( 善終 ) 確保臨終者能安詳的往生, 家屬能夠無憾平安地度過哀傷期, 回歸有意義的生活
謝謝大家聆聽祝大家智慧慈悲又健康! 平安喜樂過百歲!